On trailing earnings, T is cheaper: AZN trades at a 26.92 P/E and T at 7.94.

Which has grown faster, AZN or T?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus T at -6.06%.

Does AZN or T pay a bigger dividend?

AZN yields 1.79% and T yields 4.71% based on trailing dividends and the latest price.

Is AZN or T more profitable?

AZN runs the higher net margin — AZN at 17.19% versus T at 16.89%.

Which has been the better investment, AZN or T?

Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus T at 4.53%. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs AT&T Inc. (T)

AZN and T are evenly matched — 8 metrics each of 16.

A side-by-side comparison of AstraZeneca PLC and AT&T Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

$23.58Communication Services

Total return — AZN vs T

growth of $100 · last 30y

AZN +732.9%T +28.2%AZN compounded faster

Log scale — wide-divergence pair

AZN T

AZN vs T: by the numbers

•AZN is the larger company ($277.22B vs $163.84B market cap).
•T trades at the lower earnings multiple (7.94 vs 26.92 P/E).
•AZN converts more revenue to profit (17.19% vs 16.89% net margin).
•AZN grew revenue faster over the past five years (16.99% vs -6.06% CAGR).
•T pays the higher dividend yield (4.71% vs 1.79%).

Which is better, AZN or T?

Metric tally: AZN 8 · T 8

It depends on what you're optimizing for:

ValueT(lower P/E)

GrowthAZN(faster 5Y revenue CAGR)

IncomeT(higher dividend yield)

QualityAZN(higher ROIC)

Metrics side by side

Valuation

Metric	AZN	T
P/E ratio	26.92	7.94●
Forward P/E	15.33	9.28●
P/S ratio	4.62	1.31●
P/B ratio	5.90	1.51●
PEG ratio	0.14	0.08●
EV / EBITDA	14.92	5.88●
FCF yield	2.89%	10.47%●

Profitability

Metric	AZN	T
Gross margin	81.68%●	79.66%
Operating margin	23.69%●	19.35%
Net margin	17.19%	16.89%
ROE	21.95%●	19.48%
ROIC	13.03%●	5.57%

Dividends

Metric	AZN	T
Dividend yield	1.79%	4.71%●
Payout ratio	48.48%	36.51%

Growth (annualized)

Metric	AZN	T
Revenue CAGR (5Y)	16.99%●	-6.06%
EPS CAGR (5Y)	22.02%●	8.15%
FCF CAGR (5Y)	15.68%●	-10.02%
Total return CAGR (5Y)	11.03%●	7.79%

Frequently asked

Which is better, AZN or T?: It depends on your goal. value: T (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: T (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, they are evenly matched.
Is AZN or T cheaper?: On trailing earnings, T is cheaper: AZN trades at a 26.92 P/E and T at 7.94.
Which has grown faster, AZN or T?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus T at -6.06%.
Does AZN or T pay a bigger dividend?: AZN yields 1.79% and T yields 4.71% based on trailing dividends and the latest price.
Is AZN or T more profitable?: AZN runs the higher net margin — AZN at 17.19% versus T at 16.89%.
Which has been the better investment, AZN or T?: Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus T at 4.53%. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full T analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio AT&T P/E ratio AstraZeneca dividend yield AT&T dividend yield AstraZeneca ROE AT&T ROE AstraZeneca operating margin AT&T operating margin AstraZeneca revenue growth AT&T revenue growth AstraZeneca free cash flow AT&T free cash flow

AstraZeneca & AT&T appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.